Focal Hand Dystonia Clinical Trial
Official title:
Impact Of Physiotherapy And Botulinum Toxin Type-A In Improving Functional Outcomes In Upper Limb Focal Dystonia Among Post Stroke Patients
This study was conducted to assess the combine role of Physiotherapy by providing task specific trainings and Botulinum Toxin Type A in improving the functional outcomes of upper limb in post stroke patients with focal hand dystonia.
Post-stroke hemiparesis, with dystonia, is a major cause of disability. Dystonia can hinder the functional activities making patient dependent on others for performance of daily living activities. Dystonia not only limits the physical activity of the patient but also affects their quality of life significantly. Various treatment protocols have been used in the literature for treatment of focal hand dystonia in the past including deep brain stimulation, kinesio taping, sensory oriented training, splinting, extracorporeal shock wave therapy and botox. Out of these Botox has gained much importance but it results only in improving the passive range of motion and has no consensus in improving the active range of motion and functional independence of the patient. The current study was planned to determine the effects of botulinum toxin type A combined with task-specific therapy, for post-stroke focal dystonia of upper limb. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00376753 -
Muscle Contraction in Patients With Focal Hand Dystonia
|
N/A | |
Completed |
NCT00325091 -
Long-Term Motor Learning in Focal Hand Dystonia
|
||
Recruiting |
NCT00579033 -
Somatosensory Processing in Focal Hand Dystonia
|
N/A | |
Completed |
NCT00106782 -
Transcranial Electrical Polarization to Treat Focal Hand Dystonia
|
Phase 2 | |
Recruiting |
NCT03977493 -
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia
|
Phase 3 |